Similar articles

• Healing the Syk through kinase inhibitors.

  Rivera J, Colbert RA. Rivera J, et al. N Engl J Med. 2010 Sep 30;363(14):1362-4. doi: 10.1056/NEJMe1006527. Epub 2010 Sep 22. N Engl J Med. 2010. PMID: 20879886 No abstract available.
• Spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.

  Okamoto H, Kobayashi A. Okamoto H, et al. N Engl J Med. 2011 Jan 6;364(1):83-4; author reply 84. doi: 10.1056/NEJMc1012187. N Engl J Med. 2011. PMID: 21208113 No abstract available.
• An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.

  Weinblatt ME, Kavanaugh A, Genovese MC, Musser TK, Grossbard EB, Magilavy DB. Weinblatt ME, et al. N Engl J Med. 2010 Sep 30;363(14):1303-12. doi: 10.1056/NEJMoa1000500. Epub 2010 Sep 22. N Engl J Med. 2010. PMID: 20879879 Clinical Trial.
• Promising new treatments for rheumatoid arthritis - the kinase inhibitors.

  Yazici Y, Regens AL. Yazici Y, et al. Bull NYU Hosp Jt Dis. 2011;69(3):233-7. Bull NYU Hosp Jt Dis. 2011. PMID: 22035435 Review.
• Role of spleen tyrosine kinase inhibitors in the management of rheumatoid arthritis.

  Scott DL. Scott DL. Drugs. 2011 Jun 18;71(9):1121-32. doi: 10.2165/11591480-000000000-00000. Drugs. 2011. PMID: 21711059 Review.